Changes in blood pressure after administration of hydroxocobalamin: Relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers

References

• Guidotti T. Acute cyanide poisoning in prehospital care: new challenges, new tools for intervention. Prehosp Disast Med 2006; 21(2 suppl 2)s40–s48
   PubMedGoogle Scholar
• Dart R. Hydroxocobalamin for acute cyanide poisoning: new data from preclinical and clinical studies; new results from the prehospital emergency setting. Clin Toxicol 2006; 44(suppl 1)1–3
   Google Scholar
• Hall AH, Kulig KW, Rumack BH. Suspected cyanide poisoning in smoke inhalation: complications of sodium nitrite therapy. J Toxicol Clin Exp 1989; 9: 3–9
   PubMedGoogle Scholar
• Borron SW, Baud FJ, Mégarbane B, Bismuth C. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med 2007; 25: 551–558
   PubMed Web of Science ®Google Scholar
• Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of smoke-inhalation victims treated with hydroxocobalamin. Ann Emerg Med 2007; 49: 794–801
   PubMed Web of Science ®Google Scholar
• Fortin J-L, Giocanti J-P, Ruttimann M, Kowalski JJ. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin Toxicol 2006; 44(suppl 1)37–44
   Google Scholar
• Dart RC, Bogdan GM. Acute cyanide poisoning: causes, consequences, recognition and management. Frontline First Responder 2004; 2: 19–22
   Google Scholar
• Borron SW. Recognition and treatment of acute cyanide poisoning. J Emerg Nurs 2006; 32(4 suppl)S12–8
   PubMed Web of Science ®Google Scholar
• Baud F, Borron S. Safety of hydroxocobalamin use in the prehospital setting as an antidote for smoke inhalation-associated cyanide poisoning. Abstract. Ann Emerg Med 2006; 48: 55
   PubMedGoogle Scholar
• Forsyth JC, Mueller PD, Becker CE, Osterloh J, Benowitz NL, Rumack BH, Hall AH. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol 1993; 31: 277–294
   PubMed Web of Science ®Google Scholar
• Riou B, Gerard JL, La Rochelle CD, Bourdon R, Berdeaux A, Giudicelli JF. Hemodynamic effects of hydroxocobalamin in conscious dogs. Anesthesiology 1991; 74: 552–558
   PubMed Web of Science ®Google Scholar
• Riou B, Berdeaux A, Pussard E, Giudicelli JF. Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs. Intensive Care Med 1993; 19: 26–32
   PubMed Web of Science ®Google Scholar
• Borron SW, Stonerook M, Reid F. Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs. Clin Toxicol 2006; 44(suppl 1)5–15
   PubMed Web of Science ®Google Scholar
• Uhl W, Nolting A, Golor G, Rost KL, Kovar A. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol 2006; 44(suppl 1)17–28
   Web of Science ®Google Scholar
• Gerth K, Ehring T, Braendle M, Schelling P. Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile. Clin Toxicol 2006; 44(suppl 1)29–36
   Google Scholar
• Taylor RT, Hanna ML. Binding of aquocobalamin to the histidine residues in bovine serum albumin. Arch Biochem Biophys 1970; 141: 247–257
   PubMed Web of Science ®Google Scholar
• Lien EL, Wood JM. The specificity of aquocobalamin-binding to bovine serum albumin. Biochim Biophys Acta 1972; 264: 530–537
   Google Scholar
• van Kapel J, Spijkers LJ, Lindemans J, Abels J. Improved distribution analysis of cobalamins and cobalamin analogues in human plasma in which the use of thiol-blocking agents is a prerequisite. Clin Chim Acta 1983; 131: 211–224
   PubMed Web of Science ®Google Scholar
• Pratt JM. Inorganic chemistry of vitamin B₁₂. Academic Press, London 1972; 114–178, Chapter 8.
   Google Scholar
• Gibaldi M, Perrier D. Pharmacokinetics: drugs and pharmaceutical sciences2nd. Dekker, New York 1982; 15
   Google Scholar
• Colpaert EE, Lefebvre RA. Influence of bilirubin and other antioxidants on nitrergic relaxation in the pig gastric fundus. Br J Pharmacol 2000; 129: 1201–1211
   PubMed Web of Science ®Google Scholar
• Rajanayagam MA, Li CG, Rand MJ. Differential effects of hydroxocobalamin on NO-mediated relaxations in rat aorta and anococcygeus muscle. Br J Pharmacol 1993; 108: 3–5
   PubMed Web of Science ®Google Scholar
• Correia NA, Cavalcanti PM, Oliveira RB, Ballejo G. Effect of hydroquinone, hydroxocobalamin and carboxy-PTIO on nonadrenergic noncholinergic nerve mediated relaxations of the rat duodenum. J Auton Pharmacol 1999; 19: 233–240
   PubMedGoogle Scholar
• Li CG, Rand MJ. Effects of hydroxocobalamin and carboxy-PTIO on nitrergic transmission in porcine anococcygeus and retractor penis muscles. Br J Pharmacol 1999; 127: 172–176
   PubMed Web of Science ®Google Scholar
• Greenberg SS, Xie J, Zatarain JM, Kapusta DR, Miller MJ. Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide. J Pharmacol Exp Ther 1995; 273: 257–265
   PubMed Web of Science ®Google Scholar
• Kruszyna H, Magyar JS, Rochelle LG, Russell MA, Smith RP, Wilcox DE. Spectroscopic studies of nitric oxide interactions with cobalamins: reaction of NO with superoxocobalamin(III) likely accounts for cobalamin reversal of the biological effects of NO. J Pharmacol Exp Ther 1998; 285: 665–671
   PubMed Web of Science ®Google Scholar
• Rochelle LG, Morana SJ, Kruszyna H, Russell MA, Wilcox DE, Smith RP. Interactions between hydroxocobalamin and nitric oxide: evidence for a redox reactions between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin. J Pharmacol Exp Ther 1995; 275: 48–52
   PubMed Web of Science ®Google Scholar
• Sharma VS, Pilz RB, Boss GR, Magde D. Reactions of nitric oxide with vitamin B12 and its precursor, cobinamide. Biochemistry 2003; 42: 8900–8908
   PubMed Web of Science ®Google Scholar
• Brouwer M, Chamulitrat W, Ferruzzi G, Sauls DL, Weinberg JB. Nitric oxide interactions with cobalamins: biochemical and functional consequences. Blood 1996; 88: 1857–1864
   PubMed Web of Science ®Google Scholar